- ►oncozuidwest.be [PDF] J Bruix, M Sherman, JM Llovet, M Beaugrand, … - Journal of hepatology, 2001 - Elsevier Hepatocellular carcinoma (HCC) is a neoplasm the incidence of which is
increasing worldwide, but striking geographical differences are observed for
both risk factors and occurrence [1]. HCC represents more than 5% of all ... Cited by 1104 - Related articles - BL Direct - All 9 versions
- ►annals.org TJ Liang, B Rehermann, LB Seeff, JH … - Annals of internal medicine, 2000 - Am Coll Physicians Approximately 4 million persons in the United States and probably more than 100
million persons worldwide are infected with hepatitis C virus. The virus has the
unique ability to cause persistent infection in susceptible hosts after ... Cited by 490 - Related articles - BL Direct - All 5 versions
AM Di Bisceglie - … Conference ON Management OF Hepatitis C - consensus.nih.gov 28 Hepatitis C and Hepatocellular Carcinoma Adrian M. Di Bisceglie, MD It has
become apparent that hepatitis C virus (HCV) infection is a major risk factor
for the development of hepatocellular carcinoma (HCC) worldwide. Evidence ... Cited by 419 - Related articles - View as HTML - BL Direct - All 12 versions
G Fattovich, T Stroffolini, I Zagni, F Donato - Gastroenterology, 2004 - Elsevier Emerging data indicate that the mortality rate of hepatocellular carcinoma (HCC)
associated with cirrhosis is rising in some developed countries, whereas
mortality from non-HCC complications of cirrhosis is decreasing or is ... Cited by 340 - Related articles - BL Direct - All 15 versions
- ►ucsf.edu [PDF] ML Shiffman, AM Di Bisceglie, KL Lindsay, … - Gastroenterology, 2004 - Elsevier The most effective therapy currently available for treatment of chronic
hepatitis C virus (HCV) is the combination of peginterferon and ribavirin. This
study evaluated the effectiveness of this treatment in patients who were ... Cited by 334 - Related articles - BL Direct - All 8 versions
HB El-Serag… - Hepatology, 2002 - sadieo.ucsf.edu Chronic infection with hepatitis C virus (HCV) is a major risk factor for
development of hepatocellular carcinoma (HCC). In general, HCC develops only
after 2 or more decades of HCV infection and the increased risk is ... Cited by 239 - Related articles - View as HTML - BL Direct - All 7 versions
- ►unc.edu [PDF] ML Shiffman, CM Hofmann, MJ Contos, VA … - Gastroenterology, 1999 - Elsevier Long-term sustained virological response after interferon therapy is associated
with a persistent improvement in hepatic histology. 5 , 6 and 7 In recent years
it has also become apparent that approximately 40% of nonresponders also ... Cited by 212 - Related articles - BL Direct - All 8 versions
- ►annals.org [PDF] S Kubo, S Nishiguchi, K Hirohashi, H Tanaka, … - Annals of internal medicine, 2001 - Am Coll Physicians Background: Interferon therapy decreases the incidence of hep- atocellular
carcinoma in patients with chronic hepatitis C. Objective: To evaluate effects
of interferon- on recurrence after resection of hepatitis C virus–related ... Cited by 159 - Related articles - BL Direct - All 5 versions
AM Di Bisceglie - Hepatology, 2000 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 157 - Related articles - BL Direct - All 4 versions
